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INTRODUCTION 
Parkinson’s disease is not very common but affected 
patients have progressive decline in their  quality of life 
and became dependant fot activities of daily living.1.The 
status of supine hypertension and its association with 
clinical features of hypertension are still to be 
elucidated in detail.2 The prevalence of this 
neurodegenerative disorder is rising rapidly in older 
ages affecting more than 1.7% of the population over 
the age of 65 years.3 It is estimated that by 2030 the 
current incidence of PD will double as the populations 
age globally.4 The causes of PD are mostly not 
well-known, which hampers the proper therapeutic 
programs and preventive measures to combat 
neurodegeneration. PD is a multifactorial brain 
disorder. The inherited forms of PD account for only 
10–15% of all cases, and the majority of PD cases are 
likely due to different combinations of environmental 
exposures and genetic susceptibility.5-6 Possible 
environmental exposures including alcohol intake, 
coffee, vitamin E intake and use of nonsteroidal 
anti-inflammatory drugs could reduce the PD risk;7-10 
although, pesticide exposure and milk intake could 
increase its risk.11-13 Nevertheless, at present, the 
environmental risk factors for developing PD are still not 
fully known. Hypertensive abnormalities can occur due 
to autonomic dysfunction, even before the onset of the 
classic motor symptoms of PD.14 In addition to 
orthostatic and postprandial hypotension, PD patients 
also experience nocturnal and supine hypertension, 
which suggests that BP regulation is impaired to great 
extent in these patients . The report by Tsukamoto 
found that nocturnal hypertension exists in up to 64.9% 
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ABSTRACT 
INTRODUCTION: Parkinson’s disease is a neurodegenerative disease affecting older age populations. There is variable 
evidence of its relationship with hypertension. To date most of the studies have targeted orthostatic hypotension, 
however, rare data regarding supine hypertension has been witnessed so far. This study aimed at determining the 
association of supine hypertension with Parkinson’s disease.
Methodology:  A retrospective observational study was conducted at the Department of Neurology, Pakistan Institute 
of Medical Sciences, Islamabad. Medical records of 32 patients with Parkinson’s disease were reviewed. Data included 
baseline, clinical and therapy information along with presence of supine hypertension. Ethical clearance was taken and 
administrative permission was granted by HOD. Study outcome was measured in terms of relationship of supine 
hypertension with Parkinson’s disease.
Results: Male gender (75.0%) and older age than 60 years (56.2%) was predominantly affected with PD. Almost one 
third patients had known hypertension 9 (28.1%) out of which 7 (21.9%) are on ARBs. There were 5 (15.6%) patients 
on beta blocker, 1 (3.1%) was having calcium chain blocker and 2 (6.2%) diuretics. Out of total 68.9% patients had 
supine hypertension. Duration of PD was found greater in patients with supine hypertension.
Conclusion: Supine hypertension is significantly associated with Parkinson’s disease, especially found in patients with 
longer duration of disease.
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of PD patients.15  In Pakistan , around 1 million elder 
population is living with PD and the trend is on a rise. 
Another local study estimated around half million 
people afflicted with PD.16 There seems limited data on 
the epidemiology of the disease, similarly, more deep 
insight into the causes, prevention or interventions for 
improving quality of life of these patients is required. 
The current study is aimed at establishing the risk of 
supine HTN in PD so that with early identification of 
HTN, proper management can be started. We plan to 
assess the association of supine hypertension and 
Parkinson’s Disease in patients presenting to the 
neurology clinic of a tertiary care level hospital.
METHODOLOGY:
This retrospective observational study was conducted in 
the Neurology Department, Pakistan Institute of 
Medical Sciences. The medical records of PD patients 
who came to the department over a period of 2 years 
from 2018 to 2020 was reviewed. There were 32 
patients whose medical information was complete and 
they were selected in the study. The ethical clearance 
was taken from the hospital ethics committee and 
consent and permission of the head of the department 
was taken to use the medical record of patients for this 
research. The study parameters included the baseline 
information of patients in terms of age and gender, 
moreover clinical information was based on the 
duration of disease, presentation and management of 
patients. The presence of supine hypertension was 
recorded. Data was analyzed in SPSS version 20.0 and 
the categorical variables such as gender, clinical 
presentation of hypertension, ARBs and ACBs, medical 
therapy and supine hypertension were analyzed as 
frequency and percentages. The continuous numerical 
variables like age and duration of PD were measured as 
mean and standard deviation. Further analysis was 
done to associate the baseline and clinical parameters 
with presence of supine hypertension using chi-square 
in case of categorical variable and student’s t-test in 
case of continuous numerical variables.
  
RESULTS:
In this study a total of 32 patients of Parkinson’s 
Disease were enrolled. Males were in majority 24 
(75.0%) and most of them were above 60 years of age 
and females were 8 (25.0 %). The average age of 
patients was 62.5 years. (Table 1) The mean duration 
of the PD disease was 3.4 years. Nine (28.1%) had 
known hypertensive  whereas 7 (21.9%) were taking 
ARBs. Moreover, none of the patients had taken ACE 
inhibitors. (Table 2) There were 5 (15.6%) patients on 
beta blocker therapy in this study. One (3.1%) was 
taking calcium chain blocker whereas diuretics were 
being taken by 2 (6.2%) . (Table 3) Supine 
hypertension was present in a significant proportion of 
PD cases in the current study 22 (68.7%) and this 
signifies its association with PD.(Figure I) Supine 
hypertension was found both in both genders (90.% vs 
68.2%)  and the difference in incidence could not be 
proven statistically significant (p-value, 0.18). The 
association of age distribution of PD patients and 
supine hypertension was not significant. The greater 
the duration of PD more isn the risk of supine 
hypertension (3.8 versus 2.4 years), however, this was 
borderline statistically significant (p-value, 0.09). Table 
4
Table 1: Baseline characteristics
Table 2: Clinical presentation of patients
Table 3: Therapies given to patients
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Figure I: Supine Hypertension in the study
Table 4: Association of baseline and clinical 
features with supine hypertension
DISCUSSION:
This study highlights a significant proportion of PD 
patients having supine hypertension and proving an 
association of the two conditions.As previous scientific 
evidence suggests a controversy and no clear picture of 
hypertension and PD this study validates some 
investigator’s points and proofs regarding correlation of 
hypertension with these patients.17 In this study almost 
70.0% patients were found to have supine 
hypertension, whereas their known condition was only 
in one-third of this proportion. Goldstein DS and 
colleagues in a previous study reported that pure 
autonomic failure, multiple system atrophy and 
Parkinson’s disease all featured supine hypertension, 
which was equivalent in severity with essential 
hypertension.18 Many others have also found presence 
of supine hypertension in PD. A review study by Espay A 
et al disclosed that autonomic dysfunction is present in 
most of PD patients, this dysfunction is related to 
hemodynamic abnormalities.2 Another study by 
Kaufmann H and Goldstein DS also proved that supine 
hypertension is related with autonomic dysfunction in 
Parkinson’s disease.19 Another study by Berganzo K and 
colleagues also confirmed the relationship of supine 
hypertension and Parkinson’s Disease.20 This proves 
and validates the findings of current study. Continued 
with previous literature, in the present study male 
gender and older age than 60 years was predominantly 
affected by PD. The study by Goldstein DS had also 
found male preponderance.18 Another study by Ejaz and 
colleagues also witnessed male majority and elder ages 
in PD.21 PD is an old age neurodegenerative disorder 
which has been proven many times, moreover, male 
affliction has also been witnessed.22 In the present 
study when further analysis was done to see any 
association between demographic and clinical features 
of PD patients with presence of supine hypertension, 
no significant variation was noted. Nonetheless, the 
longer duration of PD was found to be related with 
supine hypertension. There are few studies on the 
mechanisms of supine hypertension. Theoretically, 
supine hypertension could result from excessive cardiac 
output or from inappropriately high systemic vascular 
resistance.2 On the other hand many studies have 
proven the link between orthostatichypotension and 
Parkinson’s Disease.23 In brief, it can be argued that 
males of older ages are more likely to get affected by 
PD and supine hypertension is significantly related to 
the condition. Moreover, the longer duration of PD has 
been witnessed in the patients. The current study has 
many  advantages ,firstly it highlighted the significance 
of early diagnosis of HTN in supine position  when 
autonomic disturbances and othostatic hypertension 
hide its presence.Secondly, the quantification of 
hypertension in PD patients is an additional advantage, 
specially keeping in mind the lack of evidence on these 
patients. One of the limitations was absence of long 
term outcome of these patients and role of supine 
hypertension on the overall condition and its response 
to treatment. Further data on these missing loops need 
to be gathered and disseminated.
CONCLUSION:
Supine hypertension is significantly associated with 
Parkinson’s disease, especially when the duration of 
disease is already long. In this study male gender and 
older ages were found more afflicted with the disease. 
Further studies from other parts of country and 
worldwide are needed to validate the findings of this 
study. Long term outcome and role of supine 
hypertension towards drug therapy response also 
needs to be elucidated. 
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